INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
BIT:1ISRG - US46120E6023 - Common Stock
400.55 EUR
-0.2 (-0.05%)
Taking everything into account, 1ISRG scores 6 out of 10 in our fundamental rating. 1ISRG was compared to 58 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG is valued quite expensively, but it does show have an excellent growth rating. These ratings would make 1ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year 1ISRG was profitable.
In the past year 1ISRG had a positive cash flow from operations.
1ISRG had positive earnings in each of the past 5 years.
In the past 5 years 1ISRG always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 12.93%, 1ISRG belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
1ISRG's Return On Equity of 14.52% is fine compared to the rest of the industry. 1ISRG outperforms 79.31% of its industry peers.
The Return On Invested Capital of 1ISRG (11.05%) is better than 84.48% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is in line with the industry average of 8.86%.
The 3 year average ROIC (10.15%) for 1ISRG is below the current ROIC(11.05%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.93% | ||
| ROE | 14.52% | ||
| ROIC | 11.05% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1.3 Margins
1ISRG has a Profit Margin of 28.51%. This is amongst the best in the industry. 1ISRG outperforms 94.83% of its industry peers.
In the last couple of years the Profit Margin of 1ISRG has declined.
Looking at the Operating Margin, with a value of 28.93%, 1ISRG belongs to the top of the industry, outperforming 96.55% of the companies in the same industry.
In the last couple of years the Operating Margin of 1ISRG has declined.
The Gross Margin of 1ISRG (66.61%) is better than 70.69% of its industry peers.
In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.93% | ||
| PM (TTM) | 28.51% | ||
| GM | 66.61% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1ISRG is still creating some value.
Compared to 1 year ago, 1ISRG has more shares outstanding
The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.26
WACC8.74%
2.3 Liquidity
A Current Ratio of 5.64 indicates that 1ISRG has no problem at all paying its short term obligations.
The Current ratio of 1ISRG (5.64) is better than 98.28% of its industry peers.
A Quick Ratio of 4.89 indicates that 1ISRG has no problem at all paying its short term obligations.
1ISRG's Quick ratio of 4.89 is amongst the best of the industry. 1ISRG outperforms 98.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.64 | ||
| Quick Ratio | 4.89 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.97% over the past year.
1ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
The Revenue has grown by 20.77% in the past year. This is a very strong growth!
1ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)26.97%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%23.03%
Revenue 1Y (TTM)20.77%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%21.4%
3.2 Future
Based on estimates for the next years, 1ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.53% on average per year.
1ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.89% yearly.
EPS Next Y9.11%
EPS Next 2Y12.18%
EPS Next 3Y13.89%
EPS Next 5Y14.53%
Revenue Next Year19.56%
Revenue Next 2Y16.91%
Revenue Next 3Y16.15%
Revenue Next 5Y14.89%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 58.22 indicates a quite expensive valuation of 1ISRG.
1ISRG's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of 1ISRG to the average of the S&P500 Index (27.06), we can say 1ISRG is valued expensively.
1ISRG is valuated quite expensively with a Price/Forward Earnings ratio of 50.79.
62.07% of the companies in the same industry are cheaper than 1ISRG, based on the Price/Forward Earnings ratio.
1ISRG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.69.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 58.22 | ||
| Fwd PE | 50.79 |
4.2 Price Multiples
67.24% of the companies in the same industry are cheaper than 1ISRG, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ISRG is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 84.22 | ||
| EV/EBITDA | 49.19 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of 1ISRG may justify a higher PE ratio.
A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 13.89% in the coming years.
PEG (NY)6.39
PEG (5Y)5.07
EPS Next 2Y12.18%
EPS Next 3Y13.89%
5. Dividend
5.1 Amount
No dividends for 1ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ISRG (9/2/2025, 7:00:00 PM)
400.55
-0.2 (-0.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.73%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap143.59B
Analysts79
Price Target517.16 (29.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.33%
Min EPS beat(2)3.05%
Max EPS beat(2)11.61%
EPS beat(4)4
Avg EPS beat(4)11.45%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.83%
EPS beat(12)11
Avg EPS beat(12)6.4%
EPS beat(16)13
Avg EPS beat(16)4.58%
Revenue beat(2)2
Avg Revenue beat(2)1.47%
Min Revenue beat(2)1.09%
Max Revenue beat(2)1.84%
Revenue beat(4)3
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)4
Avg Revenue beat(8)0.5%
Revenue beat(12)6
Avg Revenue beat(12)0.42%
Revenue beat(16)7
Avg Revenue beat(16)0.13%
PT rev (1m)0.45%
PT rev (3m)-1.48%
EPS NQ rev (1m)1.99%
EPS NQ rev (3m)-2.78%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)0.25%
Revenue NQ rev (1m)0.74%
Revenue NQ rev (3m)0.66%
Revenue NY rev (1m)1.26%
Revenue NY rev (3m)1.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 58.22 | ||
| Fwd PE | 50.79 | ||
| P/S | 18.37 | ||
| P/FCF | 84.22 | ||
| P/OCF | 59.43 | ||
| P/B | 9.36 | ||
| P/tB | 9.54 | ||
| EV/EBITDA | 49.19 |
EPS(TTM)6.88
EY1.72%
EPS(NY)7.89
Fwd EY1.97%
FCF(TTM)4.76
FCFY1.19%
OCF(TTM)6.74
OCFY1.68%
SpS21.81
BVpS42.82
TBVpS41.98
PEG (NY)6.39
PEG (5Y)5.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.93% | ||
| ROE | 14.52% | ||
| ROCE | 14.74% | ||
| ROIC | 11.05% | ||
| ROICexc | 23.57% | ||
| ROICexgc | 24.58% | ||
| OM | 28.93% | ||
| PM (TTM) | 28.51% | ||
| GM | 66.61% | ||
| FCFM | 21.81% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexcg growth 3Y-7.59%
ROICexcg growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 144.66% | ||
| Cap/Sales | 9.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.74% | ||
| Profit Quality | 76.48% | ||
| Current Ratio | 5.64 | ||
| Quick Ratio | 4.89 | ||
| Altman-Z | N/A |
F-Score6
WACC8.74%
ROIC/WACC1.26
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)26.97%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%23.03%
EPS Next Y9.11%
EPS Next 2Y12.18%
EPS Next 3Y13.89%
EPS Next 5Y14.53%
Revenue 1Y (TTM)20.77%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%21.4%
Revenue Next Year19.56%
Revenue Next 2Y16.91%
Revenue Next 3Y16.15%
Revenue Next 5Y14.89%
EBIT growth 1Y34.69%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.31%
EBIT Next 5Y20.2%
FCF growth 1Y69.15%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y52.09%
OCF growth 3Y4.95%
OCF growth 5Y8.61%